Literature DB >> 16393779

WW or WoW: the WW domains in a union of bliss.

Marius Sudol1, Claudia C Recinos, Jennifer Abraczinskas, Jasper Humbert, Amjad Farooq.   

Abstract

WW domains are small protein modules that recognize proline-rich peptide motifs or phosphorylated-serine/threonine proline sites in cognate proteins. Within host proteins these modules are joined to other protein domains or to a variety of catalytic domains acting together as adaptors or targeting anchors of enzymes. An important aspect of signaling by WW domains is their ability to recognize their cognate ligands in tandem. Tandem WW domains not only act in a synergistic manner but also appear to chaperone the function of each other. In this review, we focus on structure, function, and mechanism of the tandem WW domains co-operativity as well as independent actions. We emphasize here the implications of tandem arrangement and cooperative function of the domains for signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16393779     DOI: 10.1080/15216540500389039

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  20 in total

Review 1.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

Review 2.  Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.

Authors:  Amjad Farooq
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-07

Review 3.  WWOX gene and gene product: tumor suppression through specific protein interactions.

Authors:  Zaidoun Salah; Rami Aqeilan; Kay Huebner
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

Review 4.  WWOX: a fragile tumor suppressor.

Authors:  Morgan S Schrock; Kay Huebner
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-22

5.  Allostery mediates ligand binding to WWOX tumor suppressor via a conformational switch.

Authors:  Brett J Schuchardt; David C Mikles; Vikas Bhat; Caleb B McDonald; Marius Sudol; Amjad Farooq
Journal:  J Mol Recognit       Date:  2015-02-19       Impact factor: 2.137

6.  Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas.

Authors:  Rozina Tufail; Mercy Jorda; Wei Zhao; Isildinha Reis; Zafar Nawaz
Journal:  Breast Cancer Res Treat       Date:  2011-03-12       Impact factor: 4.872

7.  Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.

Authors:  Mohammad Abu-Odeh; Tomer Bar-Mag; Haiming Huang; TaeHyung Kim; Zaidoun Salah; Suhaib K Abdeen; Marius Sudol; Dana Reichmann; Sachdev Sidhu; Philip M Kim; Rami I Aqeilan
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

Review 8.  The common fragile site FRA16D gene product WWOX: roles in tumor suppression and genomic stability.

Authors:  Rami I Aqeilan; Muhannad Abu-Remaileh; Mohammad Abu-Odeh
Journal:  Cell Mol Life Sci       Date:  2014-09-23       Impact factor: 9.261

9.  Ligand binding to WW tandem domains of YAP2 transcriptional regulator is under negative cooperativity.

Authors:  Brett J Schuchardt; David C Mikles; Lawrence M Hoang; Vikas Bhat; Caleb B McDonald; Marius Sudol; Amjad Farooq
Journal:  FEBS J       Date:  2014-11-04       Impact factor: 5.542

10.  Specific α-arrestins negatively regulate Saccharomyces cerevisiae pheromone response by down-modulating the G-protein-coupled receptor Ste2.

Authors:  Christopher G Alvaro; Allyson F O'Donnell; Derek C Prosser; Andrew A Augustine; Aaron Goldman; Jeffrey L Brodsky; Martha S Cyert; Beverly Wendland; Jeremy Thorner
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.